As of Dec 12
| -0.08 / -4.02%|
The 6 analysts offering 12-month price forecasts for Idera Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 8.00 and a low estimate of 4.00. The median estimate represents a +161.78% increase from the last price of 1.91.
The current consensus among 6 polled investment analysts is to Buy stock in Idera Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.